tram34 Search Results


95
MedChemExpress tram34
Microglial displacement facilitates the Ang-II-induced effect of disinhibition on glutaminergic neurons in the PVN. A – C Representative images of PVN neurons and nearby cells, via transmission electron microscopy. ( A ) the microglia and neuron are illustrated by pseudo colors, red for neuron and green for microglia; Scale bar, 10 μm; ( B ) GABA stained by colloidal gold particles in microglia, as indicated in pseudo color (light blue); Scale bar, 5 μm; ( C ) GABA stained by colloidal gold particles outside of the microglia. Scale bar, 1 μm. D The AAV injection sites and a representative image of the BSTM (bed nucleus of the stria terminalis, medial division), where the neuro-tracing virus was injected. Scale bar, 50 μm. E Representative images of glutamatergic PVN-RVLM projecting neurons (PSN, green), PV + presynaptic terminals (red), and microglia (cyan) in the PVN, showing a close spatial relationship among these cells. 3D reconstruction with z-stacked images by Imaris 9. Scale bar, as indicated. F Representative immunofluorescent image of NeuN nuclei (white), Iba1 (green), and VGAT + puncta (red) in the PVN prepared 30 min following Ang-II/saline injection. Yellow arrows in the main panel and orthogonal panels indicate sites of microglial bulbous tip contact with VGAT + terminals. Scale bar, 2 μm. G Percentage of Iba1 processes colocalizing with VGAT + puncta ( n = 4 mice). Data are expressed as the mean ± SEM. (vehicle+Ang-II vs vehicle+saline, ns, no significant difference, *** P <0.001, unpaired Student’s t -test). H Representative traces of miniature IPSCs (mIPSCs) in PVN-RVLM projecting neurons from sections with Ang-II bath application and without <t>TRAM34</t> pretreatment (a selective blocker of IKCa1 to inhibit microglial migration, 1 μmol/L, 30 min before Ang-II, no wash). I, J Summary of amplitude ( I ) and frequency ( J ) of mIPSCs before and after Ang-II application, in the presence of TRAM34 ( n = 5 mice/group. After vs Before, ** P <0.01, paired Student’s t -test). K Suppression ratio of Ang-II-induced reduction of mIPSC frequency, in the presence of TRAM34 (A17G vs WT, *** P <0.001, unpaired Student’s t -test; WT+TRAM34 vs WT, ††† P <0.001)
Tram34, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tram34/TRAM-34/pmc12789342-100-4-7
Average 95 stars, based on 1 article reviews
tram34 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

94
Alomone Labs tram 34
Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), <t>TRAM-34</t> (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.
Tram 34, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tram34/TRAM+34/pmc04449238-139-0-3
Average 94 stars, based on 1 article reviews
tram 34 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
Tocris chlorophenyl diphenylmethyl 1h pyrazole tram 34
Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), <t>TRAM-34</t> (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.
Chlorophenyl Diphenylmethyl 1h Pyrazole Tram 34, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tram34/TRAM+34/pm20808839-73-0-5
Average 94 stars, based on 1 article reviews
chlorophenyl diphenylmethyl 1h pyrazole tram 34 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

95
Tocris tram 34
Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), <t>TRAM-34</t> (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.
Tram 34, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tram34/TRAM+34/pmc05643415-62-7-8
Average 95 stars, based on 1 article reviews
tram 34 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

94
Thermo Fisher tram 34
Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), <t>TRAM-34</t> (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.
Tram 34, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tram34/TRAM+34/us10723743-936-10-27
Average 94 stars, based on 1 article reviews
tram 34 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
Selleck Chemicals tram 34
Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), <t>TRAM-34</t> (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.
Tram 34, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tram34/TRAM-34/pmc09213538-229-25-22
Average 93 stars, based on 1 article reviews
tram 34 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

92
Biosynth Carbosynth tram
Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), <t>TRAM-34</t> (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.
Tram, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tram34/TRAM+34/pmc03192660-191-21-22
Average 92 stars, based on 1 article reviews
tram - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology chlorophenyl diphenylmethyl 1h pyrazole tram 34
Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), <t>TRAM-34</t> (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.
Chlorophenyl Diphenylmethyl 1h Pyrazole Tram 34, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tram34/TRAM-34/10__2147_slash_ijn__s56578-38-17-54
Average 91 stars, based on 1 article reviews
chlorophenyl diphenylmethyl 1h pyrazole tram 34 - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

93
Toronto Research Chemicals tram 34
Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), <t>TRAM-34</t> (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.
Tram 34, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tram34/TRAM-34/pmc06213394-133-15-17
Average 93 stars, based on 1 article reviews
tram 34 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
Biomol GmbH tram-34
Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), <t>TRAM-34</t> (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.
Tram 34, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tram34/tram+34/pmc03099631-145-4-8
Average 90 stars, based on 1 article reviews
tram-34 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Wulff labs tram-34
Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), <t>TRAM-34</t> (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.
Tram 34, supplied by Wulff labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tram34/tram+34/10__1523_slash_jneurosci__2475___21__2022-222-31-51
Average 90 stars, based on 1 article reviews
tram-34 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
SMAC Corp potassium channel inhibitor tram-34
Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), <t>TRAM-34</t> (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.
Potassium Channel Inhibitor Tram 34, supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tram34/potassium+channel+inhibitor+tram+34/pm34043300-344-23-31
Average 90 stars, based on 1 article reviews
potassium channel inhibitor tram-34 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Microglial displacement facilitates the Ang-II-induced effect of disinhibition on glutaminergic neurons in the PVN. A – C Representative images of PVN neurons and nearby cells, via transmission electron microscopy. ( A ) the microglia and neuron are illustrated by pseudo colors, red for neuron and green for microglia; Scale bar, 10 μm; ( B ) GABA stained by colloidal gold particles in microglia, as indicated in pseudo color (light blue); Scale bar, 5 μm; ( C ) GABA stained by colloidal gold particles outside of the microglia. Scale bar, 1 μm. D The AAV injection sites and a representative image of the BSTM (bed nucleus of the stria terminalis, medial division), where the neuro-tracing virus was injected. Scale bar, 50 μm. E Representative images of glutamatergic PVN-RVLM projecting neurons (PSN, green), PV + presynaptic terminals (red), and microglia (cyan) in the PVN, showing a close spatial relationship among these cells. 3D reconstruction with z-stacked images by Imaris 9. Scale bar, as indicated. F Representative immunofluorescent image of NeuN nuclei (white), Iba1 (green), and VGAT + puncta (red) in the PVN prepared 30 min following Ang-II/saline injection. Yellow arrows in the main panel and orthogonal panels indicate sites of microglial bulbous tip contact with VGAT + terminals. Scale bar, 2 μm. G Percentage of Iba1 processes colocalizing with VGAT + puncta ( n = 4 mice). Data are expressed as the mean ± SEM. (vehicle+Ang-II vs vehicle+saline, ns, no significant difference, *** P <0.001, unpaired Student’s t -test). H Representative traces of miniature IPSCs (mIPSCs) in PVN-RVLM projecting neurons from sections with Ang-II bath application and without TRAM34 pretreatment (a selective blocker of IKCa1 to inhibit microglial migration, 1 μmol/L, 30 min before Ang-II, no wash). I, J Summary of amplitude ( I ) and frequency ( J ) of mIPSCs before and after Ang-II application, in the presence of TRAM34 ( n = 5 mice/group. After vs Before, ** P <0.01, paired Student’s t -test). K Suppression ratio of Ang-II-induced reduction of mIPSC frequency, in the presence of TRAM34 (A17G vs WT, *** P <0.001, unpaired Student’s t -test; WT+TRAM34 vs WT, ††† P <0.001)

Journal: Neuroscience Bulletin

Article Title: ADAM17 Supports Disinhibition of Pre-sympathetic Glutamatergic Neurons Through Microglial Chemotaxis

doi: 10.1007/s12264-025-01471-8

Figure Lengend Snippet: Microglial displacement facilitates the Ang-II-induced effect of disinhibition on glutaminergic neurons in the PVN. A – C Representative images of PVN neurons and nearby cells, via transmission electron microscopy. ( A ) the microglia and neuron are illustrated by pseudo colors, red for neuron and green for microglia; Scale bar, 10 μm; ( B ) GABA stained by colloidal gold particles in microglia, as indicated in pseudo color (light blue); Scale bar, 5 μm; ( C ) GABA stained by colloidal gold particles outside of the microglia. Scale bar, 1 μm. D The AAV injection sites and a representative image of the BSTM (bed nucleus of the stria terminalis, medial division), where the neuro-tracing virus was injected. Scale bar, 50 μm. E Representative images of glutamatergic PVN-RVLM projecting neurons (PSN, green), PV + presynaptic terminals (red), and microglia (cyan) in the PVN, showing a close spatial relationship among these cells. 3D reconstruction with z-stacked images by Imaris 9. Scale bar, as indicated. F Representative immunofluorescent image of NeuN nuclei (white), Iba1 (green), and VGAT + puncta (red) in the PVN prepared 30 min following Ang-II/saline injection. Yellow arrows in the main panel and orthogonal panels indicate sites of microglial bulbous tip contact with VGAT + terminals. Scale bar, 2 μm. G Percentage of Iba1 processes colocalizing with VGAT + puncta ( n = 4 mice). Data are expressed as the mean ± SEM. (vehicle+Ang-II vs vehicle+saline, ns, no significant difference, *** P <0.001, unpaired Student’s t -test). H Representative traces of miniature IPSCs (mIPSCs) in PVN-RVLM projecting neurons from sections with Ang-II bath application and without TRAM34 pretreatment (a selective blocker of IKCa1 to inhibit microglial migration, 1 μmol/L, 30 min before Ang-II, no wash). I, J Summary of amplitude ( I ) and frequency ( J ) of mIPSCs before and after Ang-II application, in the presence of TRAM34 ( n = 5 mice/group. After vs Before, ** P <0.01, paired Student’s t -test). K Suppression ratio of Ang-II-induced reduction of mIPSC frequency, in the presence of TRAM34 (A17G vs WT, *** P <0.001, unpaired Student’s t -test; WT+TRAM34 vs WT, ††† P <0.001)

Article Snippet: In the inhibitor group, TRAM34 (Cat.# HY-13519, MCE, China) and AZD8797 (Cat.# 2255, Axon Medchem, The Netherlands) were given 30 min before Ang-II (Cat.# 4006473, BCHEM, USA).

Techniques: Transmission Assay, Electron Microscopy, Staining, Injection, Virus, Saline, Migration

Pharmacologically blocking the CX3CL1/CX3CR1 chemotactic pathway blunts the Ang-II-induced pressor response. A Location of Cx3cl1 mRNA expression based on the single-nuclei RNA-seq data collected from the PVN and adjacent tissue. Upper panel: mRNA location; lower panel: UMAP for individual cell clusters. B , C Schematic and image of the administration route for Ang-II or antagonists. Scale bar, 50 μm. D Representative blood pressure (BP) recording traces from awake WT mice. E Summary data of the BP increase (mean arterial pressure, ΔMAP) in awake WT mice undergoing Ang-II injection (100 ng/100 nL) into the PVN with or without injection of AZD8797 (a selective blocker of CX3CR1, 5 μmol/L per 100 nL, 30 min before Ang-II injection); and with or without injection of TRAM34 (a selective blocker of IKCa1 to inhibit microglial migration, 10 mg/kg in 100 nL, 30 min before Ang-II injection). F Representative BP recordings from anesthetized WT mice. G Summary data of BP increase (ΔMAP) in anesthetized WT mice undergoing Ang-II injection (100 ng/100 nL) into the PVN with or without injection of AZD8797 (5 μmol/L per 100nL, 30 min before Ang-II injection); and with or without injection of TRAM34 (10 mg/kg in 100 nL, 30 min before Ang-II injection). Each data point represents an individual mouse, n = 7–9 mice. Data are shown as the mean ± SEM. * P <0.05, ** P <0.01, *** P <0.001 vs Ang-II, one-way ANOVA followed by Dunnett post tests

Journal: Neuroscience Bulletin

Article Title: ADAM17 Supports Disinhibition of Pre-sympathetic Glutamatergic Neurons Through Microglial Chemotaxis

doi: 10.1007/s12264-025-01471-8

Figure Lengend Snippet: Pharmacologically blocking the CX3CL1/CX3CR1 chemotactic pathway blunts the Ang-II-induced pressor response. A Location of Cx3cl1 mRNA expression based on the single-nuclei RNA-seq data collected from the PVN and adjacent tissue. Upper panel: mRNA location; lower panel: UMAP for individual cell clusters. B , C Schematic and image of the administration route for Ang-II or antagonists. Scale bar, 50 μm. D Representative blood pressure (BP) recording traces from awake WT mice. E Summary data of the BP increase (mean arterial pressure, ΔMAP) in awake WT mice undergoing Ang-II injection (100 ng/100 nL) into the PVN with or without injection of AZD8797 (a selective blocker of CX3CR1, 5 μmol/L per 100 nL, 30 min before Ang-II injection); and with or without injection of TRAM34 (a selective blocker of IKCa1 to inhibit microglial migration, 10 mg/kg in 100 nL, 30 min before Ang-II injection). F Representative BP recordings from anesthetized WT mice. G Summary data of BP increase (ΔMAP) in anesthetized WT mice undergoing Ang-II injection (100 ng/100 nL) into the PVN with or without injection of AZD8797 (5 μmol/L per 100nL, 30 min before Ang-II injection); and with or without injection of TRAM34 (10 mg/kg in 100 nL, 30 min before Ang-II injection). Each data point represents an individual mouse, n = 7–9 mice. Data are shown as the mean ± SEM. * P <0.05, ** P <0.01, *** P <0.001 vs Ang-II, one-way ANOVA followed by Dunnett post tests

Article Snippet: In the inhibitor group, TRAM34 (Cat.# HY-13519, MCE, China) and AZD8797 (Cat.# 2255, Axon Medchem, The Netherlands) were given 30 min before Ang-II (Cat.# 4006473, BCHEM, USA).

Techniques: Blocking Assay, Expressing, RNA Sequencing, Injection, Migration

Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), TRAM-34 (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.

Journal: Pulmonary Circulation

Article Title: Functional coupling of TRPV4, IK, and SK channels contributes to Ca 2+ -dependent endothelial injury in rodent lung

doi: 10.1086/680166

Figure Lengend Snippet: Whole-cell voltage-clamp recordings in PMVECs. A, Voltage-clamp recording protocol. Cells were held at their resting potential and stepped to −80 mV for 100 ms before a voltage ramp of −80 to +60 mV (200 ms), a voltage step to +30 mV (100 ms), and return to resting potential. B, Representative whole-cell current densities elicited by the voltage-clamp protocol shown in A. After stable baseline recordings (control), sequential additions of paxilline (1 μM), TRAM-34 (1 μM), and apamin (200 nM) selectively blocked BK, IK, and SK channels, respectively. C–E, BK (C), IK (D), and SK (E) currents were isolated from digital subtraction of the voltage-ramp portion of traces in B. F, Normalized BK, IK, and SK channel current density to whole-cell current density, calculated from the steady-state current density recordings at +30 mV. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; PMVECs: pulmonary microvascular endothelial cells; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.

Article Snippet: TRAM-34 was from Alomone Labs. All other chemicals were obtained from Fisher Scientific (Pittsburgh, PA).

Techniques: Isolation

TRPV4 channel activation increases IK and SK channel current densities. A, Representative whole-cell current densities elicited by the 200-ms −80 to +60 mV voltage-ramp protocol. Following stable baseline recordings, GSK (50 nM) was used to activate TRPV4 channels. Sequential applications of paxilline (500 nM), TRAM-34 (1 μM), and apamin (200 nM) were used to selectively inhibit BK, IK, and SK channels, respectively. B, Bar graph showing BK, IK, and SK channel current densities, in the presence of GSK, normalized to baseline whole-cell current density (control in A). Normalized results were calculated from the steady-state current density recordings at +30 mV. Dashed lines indicate normalized averages of each channel current density in the absence of GSK, as shown in Figure 2F. Asterisks indicate statistical significance (P < 0.05). C–F, The effect of GSK (C), paxilline (D), TRAM-34 (E), and apamin (F) on whole-cell current density isolated from digital subtraction of the traces shown in A. Averaged membrane capacitance was 23.8 ± 3.2 pF. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; GSK: GSK1016790A; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole; TRPV4: transient receptor potential vanilloid 4.

Journal: Pulmonary Circulation

Article Title: Functional coupling of TRPV4, IK, and SK channels contributes to Ca 2+ -dependent endothelial injury in rodent lung

doi: 10.1086/680166

Figure Lengend Snippet: TRPV4 channel activation increases IK and SK channel current densities. A, Representative whole-cell current densities elicited by the 200-ms −80 to +60 mV voltage-ramp protocol. Following stable baseline recordings, GSK (50 nM) was used to activate TRPV4 channels. Sequential applications of paxilline (500 nM), TRAM-34 (1 μM), and apamin (200 nM) were used to selectively inhibit BK, IK, and SK channels, respectively. B, Bar graph showing BK, IK, and SK channel current densities, in the presence of GSK, normalized to baseline whole-cell current density (control in A). Normalized results were calculated from the steady-state current density recordings at +30 mV. Dashed lines indicate normalized averages of each channel current density in the absence of GSK, as shown in Figure 2F. Asterisks indicate statistical significance (P < 0.05). C–F, The effect of GSK (C), paxilline (D), TRAM-34 (E), and apamin (F) on whole-cell current density isolated from digital subtraction of the traces shown in A. Averaged membrane capacitance was 23.8 ± 3.2 pF. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; GSK: GSK1016790A; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole; TRPV4: transient receptor potential vanilloid 4.

Article Snippet: TRAM-34 was from Alomone Labs. All other chemicals were obtained from Fisher Scientific (Pittsburgh, PA).

Techniques: Activation Assay, Isolation

TRPV4 channel inhibition reduces IK and SK channel current densities. A, Representative whole-cell current density elicited by the 200-ms −80 to +60 mV voltage-ramp protocol. Following stable baseline recordings (control), HC (500 nM) was used to inhibit TRPV4 channels. Sequential applications of paxilline (500 nM), TRAM-34 (1 μM), and apamin (200 nM) were used to selectively inhibit BK, IK, and SK channels, respectively. B, Bar graph showing BK, IK, and SK channel current densities in the presence of HC, normalized to baseline whole-cell current density (control in A). Normalized results were calculated from the steady-state current density recordings at +30 mV. Dashed lines indicate normalized averages of each channel current density in the absence of HC, as shown in Figure 2F. Asterisks indicate statistical significance (P < 0.05). C–F, The effect of HC (C), paxilline (D), TRAM-34 (E), and apamin (F) on whole-cell current density isolated from digital subtraction of the traces shown in A. Averaged membrane capacitance was 22.3 ± 4.5 pF. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; HC: HC067047; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole; TRPV4: transient receptor potential vanilloid 4.

Journal: Pulmonary Circulation

Article Title: Functional coupling of TRPV4, IK, and SK channels contributes to Ca 2+ -dependent endothelial injury in rodent lung

doi: 10.1086/680166

Figure Lengend Snippet: TRPV4 channel inhibition reduces IK and SK channel current densities. A, Representative whole-cell current density elicited by the 200-ms −80 to +60 mV voltage-ramp protocol. Following stable baseline recordings (control), HC (500 nM) was used to inhibit TRPV4 channels. Sequential applications of paxilline (500 nM), TRAM-34 (1 μM), and apamin (200 nM) were used to selectively inhibit BK, IK, and SK channels, respectively. B, Bar graph showing BK, IK, and SK channel current densities in the presence of HC, normalized to baseline whole-cell current density (control in A). Normalized results were calculated from the steady-state current density recordings at +30 mV. Dashed lines indicate normalized averages of each channel current density in the absence of HC, as shown in Figure 2F. Asterisks indicate statistical significance (P < 0.05). C–F, The effect of HC (C), paxilline (D), TRAM-34 (E), and apamin (F) on whole-cell current density isolated from digital subtraction of the traces shown in A. Averaged membrane capacitance was 22.3 ± 4.5 pF. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; HC: HC067047; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole; TRPV4: transient receptor potential vanilloid 4.

Article Snippet: TRAM-34 was from Alomone Labs. All other chemicals were obtained from Fisher Scientific (Pittsburgh, PA).

Techniques: Inhibition, Isolation

Role of KCa channels in the 14,15-EET-induced permeability response. Permeability increased significantly with 14,15-EET (3 μM, n = 5) in lungs from wild-type mice. This response was attenuated in low-Ca2+ buffer and was restored by Ca2+ add-back. Pretreatment of lungs with iberiotoxin (IbTx, 100 nM, n = 5) had no effect on the Kf response to 14,15-EET. In contrast, pretreatment of lungs with the combination of charybdotoxin (ChTx, 100 nM) and apamin (300 nM) to block all KCa channels (n = 4), with apamin alone to block SK channels (300 nM, n = 5), or with TRAM-34 (1 μM, n = 5) to block IK channels significantly attenuated this response. Note that 14,15-EET had no effect in any group in low-Ca2+ buffer. Asterisks indicate P < 0.05; only groups with 14,15-EET alone or 14,15-EET in presence of IbTx showed significant increases in permeability (response in low vs. normal Ca2+ or baseline [BL] vs. normal Ca2+), 2-way ANOVA. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; 14,15-EET: 14,15-epoxyeicosatrienoic acid; KCa: Ca2+-activated potassium; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.

Journal: Pulmonary Circulation

Article Title: Functional coupling of TRPV4, IK, and SK channels contributes to Ca 2+ -dependent endothelial injury in rodent lung

doi: 10.1086/680166

Figure Lengend Snippet: Role of KCa channels in the 14,15-EET-induced permeability response. Permeability increased significantly with 14,15-EET (3 μM, n = 5) in lungs from wild-type mice. This response was attenuated in low-Ca2+ buffer and was restored by Ca2+ add-back. Pretreatment of lungs with iberiotoxin (IbTx, 100 nM, n = 5) had no effect on the Kf response to 14,15-EET. In contrast, pretreatment of lungs with the combination of charybdotoxin (ChTx, 100 nM) and apamin (300 nM) to block all KCa channels (n = 4), with apamin alone to block SK channels (300 nM, n = 5), or with TRAM-34 (1 μM, n = 5) to block IK channels significantly attenuated this response. Note that 14,15-EET had no effect in any group in low-Ca2+ buffer. Asterisks indicate P < 0.05; only groups with 14,15-EET alone or 14,15-EET in presence of IbTx showed significant increases in permeability (response in low vs. normal Ca2+ or baseline [BL] vs. normal Ca2+), 2-way ANOVA. BK, IK, SK: large-, intermediate-, and small-conductance KCa (Ca2+-activated potassium) channels, respectively; 14,15-EET: 14,15-epoxyeicosatrienoic acid; KCa: Ca2+-activated potassium; TRAM-34: 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole.

Article Snippet: TRAM-34 was from Alomone Labs. All other chemicals were obtained from Fisher Scientific (Pittsburgh, PA).

Techniques: Permeability, Blocking Assay